Kirubel Frew

Kirubel Frew is an accomplished business development executive with extensive experience in the healthcare and biotechnology sectors. Currently serving as Vice President of Business Development at Viz.ai, Kirubel leads initiatives for an AI-powered platform focused on disease detection and patient care coordination. Prior roles include VP of Healthcare at Axion Ray, where Kirubel contributed to an AI platform for manufacturing analytics; Vice President of Business Development at Anumana, specializing in ECG-AI algorithms for cardiovascular disease; and Head of Business Development & Product Strategy at nference. Kirubel's career also encompasses roles as a healthcare investment banker at Lazard, venture creation at Flagship Pioneering, and founding team member at SQZ Biotechnologies, where Kirubel co-invented a methodology for biomolecule delivery. Kirubel began in research as a scientist at the Ragon Institute and holds an MBA in Finance from the University of Southern California, a Bachelor of Science in Chemistry from Augsburg University, and has been a visiting student at the Massachusetts Institute of Technology in Biological Engineering.